Consensus Statement: Cardiovascular Safety Profile of Triptans (5‐HT1B/1D Agonists) in the Acute Treatment of Migraine
暂无分享,去创建一个
S. Hahn | R. Lipton | K. Welch | S. Silberstein | W. Rosamond | D. Matchar | V. Papademetriou | D. Dodick | P. Goadsby | V. Martin | R. Purdy | A. Maassenvandenbrink | H. Loutfi | J. Saiers | Susan Hutchinson | T. Smith